Streetbeat News

ALUR

Allurion Technologies Inc.

https://www.allurion.com

Industry

Medical - Devices

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Chardan Capital has maintained a Buy rating on Allurion Technologies but has lowered the price target from $5 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:09 pm

Allurion Technologies, Inc. (NYSE:ALUR) received a notice from the NYSE for not meeting the continued listing standards, as its stock price averaged below $1.00 per share over a 30-day period. This notice does not result in immediate delisting.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:08 pm

Allurion Technologies shares are trading lower due to continued weakness following the company's weak FY24 revenue guidance reported yesterday.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 4:14 pm

Allurion Technologies has revised its full-year 2024 revenue guidance to $40 million-$45 million, down from the previous $60 million-$65 million, and below the $55 million estimate. The company expects a 10%-15% growth in procedure volume.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:04 pm

Allurion Technologies reported a Q2 EPS of $(0.05), beating the estimate of $(0.24). Sales were $11.77M, surpassing the $10.90M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:01 pm

Allurion Technologies shares are trading lower after the company priced a $20 million public offering.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:34 pm

Allurion Technologies, Inc. (NYSE: ALUR) announced a public offering of 14,406,508 shares of its common stock at $1.20 per share, raising $17.3 million. Additionally, a $2.7 million private placement with RTW Investments will bring total proceeds to $20 million. The offering is expected to close around July 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:08 pm

Allurion Technologies shares are trading lower following the announcement of an underwritten public offering of up to $20 million in common stocks and warrants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:36 pm

Allurion has announced an underwritten public offering of up to $20 million in common stocks and warrants.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 12:36 pm

Kaival Brands Innovations Group (NASDAQ:KAVL) shares dropped 47% after announcing a $6.0 million public offering. Other notable movers include American Rebel Holdings (NASDAQ:AREB) up 161% due to a new distribution agreement, and Sharecare (NASDAQ:SHCR) up 74% following an acquisition agreement.

Portfolio Pulse from Avi Kapoor

June 21, 2024 | 6:04 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.